AlphaGrep UK Ltd bought a new stake in The Allstate Corporation (NYSE:ALL – Free Report) in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 4,793 shares of the insurance provider’s stock, valued at approximately $1,063,000. Allstate comprises approximately 0.3% of AlphaGrep UK Ltd’s investment portfolio, making the stock its 28th biggest position.
A number of other hedge funds have also recently made changes to their positions in ALL. BlackRock Inc. bought a new position in shares of Allstate during the second quarter valued at $5,439,448,000. Bank of America Corp DE grew its holdings in Allstate by 8.1% in the first quarter. Bank of America Corp DE now owns 7,913,320 shares of the insurance provider’s stock worth $1,640,748,000 after purchasing an additional 596,321 shares during the period. GQG Partners LLC bought a new stake in Allstate in the second quarter valued at $1,245,710,000. Deutsche Bank AG bought a new stake in Allstate in the second quarter valued at $1,008,648,000. Finally, First Trust Advisors LP increased its stake in Allstate by 5.0% in the third quarter. First Trust Advisors LP now owns 2,559,539 shares of the insurance provider’s stock valued at $567,859,000 after purchasing an additional 121,426 shares in the last quarter. 76.47% of the stock is owned by institutional investors and hedge funds.
Allstate Stock Performance
ALL stock opened at $266.99 on Friday. The company has a quick ratio of 0.37, a current ratio of 0.37 and a debt-to-equity ratio of 0.25. The firm has a market cap of $66.07 billion, a PE ratio of 6.05, a P/E/G ratio of 1.16 and a beta of 0.13. The business has a 50 day moving average of $247.52 and a 200-day moving average of $233.24. The Allstate Corporation has a 12-month low of $191.13 and a 12-month high of $281.11.
Allstate Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Monday, January 4th. Investors of record on Monday, November 30th will be issued a dividend of $1.08 per share. This represents a $4.32 dividend on an annualized basis and a yield of 1.6%. The ex-dividend date is Monday, November 30th. Allstate’s dividend payout ratio (DPR) is 9.78%.
Analyst Upgrades and Downgrades
A number of brokerages have commented on ALL. Zacks Research cut Allstate from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, September 15th. HSBC downgraded Allstate from a “buy” rating to a “hold” rating and set a $271.00 price objective for the company. in a report on Friday, November 6th. TD Cowen raised their price objective on shares of Allstate from $231.00 to $260.00 and gave the company a “hold” rating in a research note on Wednesday, September 23rd. Evercore lifted their price objective on shares of Allstate from $240.00 to $262.00 in a report on Thursday, October 8th. Finally, The Goldman Sachs Group decreased their target price on shares of Allstate from $280.00 to $250.00 and set a “neutral” rating for the company in a research report on Thursday, October 1st. Two research analysts have rated the stock with a Strong Buy rating, seven have assigned a Buy rating, ten have issued a Hold rating and three have given a Sell rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Hold” and an average target price of $274.90.
Check Out Our Latest Stock Report on ALL
Key Stories Impacting Allstate
Investors following ALL have been watching these stories:
- Positive Sentiment: Mizuho raised its price target to $311 from $295 and reiterated an “outperform” rating, implying 16.5% upside from the cited $266.99 share price. Mizuho ratings
- Positive Sentiment: Zacks Research lifted estimates for several periods, including fiscal 2026 EPS to $37.28 from $33.83 and fiscal 2028 EPS to $26.52 from $24.42. These upward revisions offer a positive earnings signal, although Zacks maintains a “hold” rating. Allstate analyst coverage
- Neutral Sentiment: Other Zacks revisions were mixed: some 2027 quarterly forecasts were raised, while estimates for Q1 2028 and Q3 2027 were lowered. A separate report cited an average analyst price target of $273.48, suggesting more limited upside than Mizuho’s target. Average analyst price target report
Allstate Profile
Allstate Corporation is a U.S.-based insurance company that provides property and casualty coverage and related protection products. Its offerings include auto, homeowners, renters, condominium, motorcycle and recreational vehicle insurance, as well as life insurance and roadside assistance. The company sells products through its Allstate-branded business and other businesses, including National General, using agents and direct-to-consumer channels. Allstate primarily serves customers in the United States.
See Also
- Five stocks we like better than Allstate
- ZIM Just Posted Huge Profits, But Its $35 Buyout Is Still in Limbo
- Owens Corning’s Stock Slump May Have a Silver Lining for Dividend Investors
- The Patchpocalypse Could Be a Big Opportunity for These 2 Cybersecurity Stocks
- Anthropic’s Record IPO Could Ease a Major Concern for Broadcom Investors
Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Corporation (NYSE:ALL – Free Report).
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.
